A Phase 2 interventional study of SIDI and SC in Substance Dependence, sponsored by University of South Florida. Status unknown at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-10-11.
Sponsored by University of South Florida · Phase 2, Interventional, and Treatment
Despite recent advances in substance abuse interventions, a large percentage of clients entering residential treatment for substance use will drop out of treatment prematurely, and of the remaining, many will relapse soon after treatment completion. Previous research indicates that an individual's ability to withstand psychological distress is a key factor necessary to maintain drug and alcohol abstinence and to remain in substance use treatment without absconding. In previous work, Dr. Bornovalova developed a specific distress tolerance treatment called Skills for Improving Distress Intolerance (SIDI). This intervention features skills training in behavioral and acceptance strategies and intentional clinical exposure to emotional distress. SIDI was developed and piloted with a sample of urban drug users seeking treatment in a residential facility. Individuals receiving SIDI exhibited greater improvement in distress tolerance than those in two comparison groups (receiving treatment-as-usual and supportive counseling).
Current study. The investigators received NIDA funding to conduct a randomized clinical trial with 325 clients entering a residential substance use treatment facility. Study participants will be randomized into two treatment groups: (1) those receiving SIDI and (2) those receiving Supportive Counseling (SC). Participants will receive 10 treatment sessions over a period of 4 months. Then, the investigators will follow clients for one year to examine treatment retention and abstinence.
2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.
This study's planned enrollment of 325 is above the median of 108 across 1,727 interventional studies indexed under Substance-Related Disorders.
Browse Substance-Related Disorders studies →University of South Florida is the lead sponsor of 333 studies on the registry; 63 are open to participants now.
Of its 17 completed or terminated interventional studies of FDA-regulated products, 4 (24%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
Skills for Improving Distress Intolerance treatment protocol: individual, manualized treatment aimed at improving distress intolerance
Behavioral: SIDI
supportive counseling; psychological placebo/talk therapy - aimed at controlling for non-specific therapeutic factors
Behavioral: SC
Also known as: Skills for improving distress intolerance
Also known as: supportive counseling
abstinence at 1, 3, 6 & 12 month follow-up
Measured via biological verification and timeline follow-back
Time frame: 1, 3, 6 month follow-up post-treatment
distress tolerance
ability to tolerate psychological distress
Time frame: 1, 3, 6 month follow-up
successful/unsuccessful completion of residential addictions treatment
successful/unsuccessful completion of residential addictions treatment
Time frame: Baseline, post-treatment (at 3 month mark in residential facility), successful discharge within 6 months from residential facility
time in jail
measured by public records (# of days in jail by each timepoint)
Time frame: 1, 3, 6 month follow-up in community
psychiatric distress
psychiatric distress on brief symptom inventory
Time frame: post-treatment at 3 month mark in residential facility, 1, 3, 6 month follow-up in community
maladaptive personality
change in maladaptive personality on the Personality Inventory for DSM5
Time frame: post-treatment (at 3 month mark in residential facility), 1, 3, 6 month follow-up in community
This study is status unknown, as verified in May 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of South Florida